Aptamer Group has entered into its first licensing agreement with Twist Bioscience, granting a non-exclusive licence for the use of an Optimer® binder in hot-start PCR and next-generation sequencing products...
Manx Financial has announced the exercise of Restricted Stock Units over 2,072,500 new ordinary shares at nil cost. The share issues relate to vested awards granted in November 2023 and include allocations to directors and a PDMR, with admission to trading on AIM expected on 23 December 2025...
The AIM listed finance provider recorded higher new business origination, an expanded lending book, and increased profit before tax, alongside lower arrears and write-offs, supporting confidence that full year performance will be in line with market guidance...
Beeks Financial Cloud Group has signed a multi-year Exchange Cloud agreement with nuam, the integrated exchange group covering Chile, Colombia and Peru...
Filtronic has received an Authorisation to Proceed worth approximately £7m from a major European defence prime for the next phase of an electronic sensor programme...
Tern Plc has received about £230,000 in new unsecured convertible loan notes from Talking Medicines after cancelling around £180,000 of short term loans provided over 2024 and 2025...
Global Opportunities Trust delivered a 24.9% share price gain over 12 months, driven by disciplined global value investing across public and private market assets...
Ilika plc has shipped its 10Ah Goliath solid-state battery prototypes, marking a major scale-up from earlier designs. CEO Graeme Purdy outlines how higher-energy materials and an automated pilot line delivered a 93% yield, signalling readiness for larger-scale manufacturing...
CMC Markets’ CEO Lord Peter Cruddas argues it’s time for a market re-rating. With $150bn in client assets and global tech deals from Westpac to Revolut, the business is no longer just a B2C trading firm—it’s a tech-driven financial engine...
Escape Hunt drives XP Factory’s performance with sector-leading margins and positive like-for-likes, while Boom Battle Bar sharpens its rollout strategy and delivers margin gains despite market headwinds...
Elemental Royalty CEO David Cole explains how smart capital allocation and discovery optionality turn modest royalty deals into multi-decade, cash-generating assets with scale...
Cerillion’s Louis Hall breaks down a record year of performance, including a major new market entry in Armenia and a £25m expansion in Europe. With a robust order pipeline and shrinking competition, Cerillion is well-positioned to build on its momentum heading into FY26...
NB Private Equity Partners: Analyst Mark Thomas explains how rising exits, midlife co-investments and accelerated buybacks suggest NBPE is on track for a rebound. Could the second half of 2025 be the turning point investors have been waiting for?..
Outages at AWS and Cloudflare aren’t just inconvenient — they’re a wake-up call. Verge Technologies CEO Jimmy Jobe explains how SentientDB keeps databases globally available, with zero downtime and full automation...
Jason Streets of Hardman & Co explains why Cavendish Plc’s strong cash position and consistent earnings make it one of the UK’s most resilient small-cap investment banks — even as M&A volumes slide...
Graeme Purdy, CEO of Ilika plc, outlines how solid-state Stereax batteries are entering production at Cirtec—with customer-ready units already on test. Applications span implanted sensors to orthodontics, and next-gen Goliath cells are primed for delivery by year-end...
Meren Energy’s Shahin Amini reveals how the company delivered $100M in dividends, halved debt, and secured funding for the Venus field — all while positioning for high-impact drilling in Nigeria and Namibia..
Centrica has announced the sale of Spirit Energy’s remaining interests in the Cygnus gas field and other producing assets in the Southern North Sea to Serica Energy...
AstraZeneca and Daiichi Sankyo have received US FDA approval for Enhertu in combination with pertuzumab as a 1st-line treatment for adults with unresectable or metastatic HER2-positive breast cancer...
GSK has announced that Exdensur (depemokimab) has received marketing authorisation from the UK MHRA for use in certain asthma and chronic rhinosinusitis with nasal polyps patients...
Anglo American and Teck Resources have received approval from the Government of Canada under the Investment Canada Act for their proposed merger of equals...
GSK has announced that the EMA’s CHMP has recommended broadening the indication of its adjuvanted RSV vaccine to adults aged 18 and over, with a final decision expected in February 2026...
PPHE Hotel Group has agreed a new £88 million refinancing facility for Park Plaza Victoria London, replacing an existing loan due to mature in early 2026...
Hollywood Bowl Group has published its audited results for the year ended 30 September 2025, reporting revenue growth of 8.8% to £250.7m and a fourth consecutive year of record revenue and adjusted EBITDA...
Harbour Energy has agreed to acquire most subsidiaries of Waldorf Energy Partners and Waldorf Production for $170 million, a move expected to add 20 kboepd of oil weighted production and 35 mmboe of 2P reserves...
TwentyFour Income Fund noted improved market sentiment in November, supported by progress in Ukraine peace discussions and a stable UK Budget response...
